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Background: Aspiration pneumonia has been a growing interest in an aging population. Anaerobes are important
pathogens, however, the etiology of aspiration pneumonia is not fully understood. In addition, the relationship
between the patient clinical characteristics and the causative pathogens in pneumonia patients with aspiration risk
factors are unclear. To evaluate the relationship between the patient clinical characteristics with risk factors for
aspiration and bacterial flora in bronchoalveolar lavage fluid (BALF) in pneumonia patients, the bacterial floral
analysis of 16S ribosomal RNA gene was applied in addition to cultivation methods in BALF samples.
Methods: From April 2010 to February 2014, BALF samples were obtained from the affected lesions of pneumonia
via bronchoscopy, and were evaluated by the bacterial floral analysis of 16S rRNA gene in addition to cultivation
methods in patients with community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP).
Factors associated with aspiration risks in these patients were analyzed.
Results: A total of 177 (CAP 83, HCAP 94) patients were enrolled. According to the results of the bacterial floral
analysis, detection rate of oral streptococci as the most detected bacterial phylotypes in BALF was significantly
higher in patients with aspiration risks (31.0 %) than in patients without aspiration risks (14.7 %) (P = 0.009). In
addition, the percentages of oral streptococci in each BALF sample were significantly higher in patients with
aspiration risks (26.6 ± 32.0 %) than in patients without aspiration risks (13.8 ± 25.3 %) (P = 0.002). A multiple linear
regression analysis showed that an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of ≥3, the
presence of comorbidities, and a history of pneumonia within a previous year were significantly associated with a
detection of oral streptococci in BALF.
Conclusions: The bacterial floral analysis of 16S rRNA gene revealed that oral streptococci were mostly detected as
the most detected bacterial phylotypes in BALF samples in CAP and HCAP patients with aspiration risks, especially
in those with a poor ECOG-PS or a history of pneumonia.
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Pneumonia is the third and ninth most common cause of
death in Japan [1] and the United States [2], respectively.
As the population ages, the mortality associated with
pneumonia is increasing, especially among the elderly
population of over 65 years of age [1].
The detection of the causative pathogens in pneumo-
nia patients is generally based on sputum culture [3],
but molecular methods using 16S ribosomal RNA gene
sequence have yielded new bacteriological information
for pneumonia [4–7]; specifically, that anaerobes and oral
streptococci are important pathogens for community-
acquired pneumonia (CAP) [5], healthcare-associated
pneumonia (HCAP) [7], ventilator-associated pneumonia
(VAP) [4, 6], and bacterial pleurisy [8]. The bacterial
floral analysis of 16S rRNA gene we used have the
advantages that can evaluate the ratio of each bacter-
ial phylotype in each sample in addition to the ability
to detect bacterial phylotypes that are difficult or im-
possible to be cultured [5, 7, 8].
Aspiration risks are important factors in elderly pa-
tients with pneumonia [9], as it can be highly influential
to the causative pathogens. The guidelines for pneumo-
nia recommend the use of effective antimicrobials to
anaerobes in patients who are at risk for aspiration [10],
however, there is insufficient etiological information of
causative bacteria in these patients [11].
The objective of this study was to evaluate detected
bacterial phylotypes by the bacterial floral analysis of
16S rRNA gene in addition to cultivation methods in
bronchoalveolar lavage fluid (BALF) in patients with
CAP and HCAP, and also to assess the relationship
between the patient clinical characteristics with risk
factors for aspiration and the most detected bacterial
phylotypes by the bacterial floral analysis, using both
simple and multiple regression analyses.
Methods
Study population
We recruited CAP (83) and HCAP (94) patients at
the University of Occupational and Environmental
Health, Japan and referred community hospitals be-
tween April 2010 and February 2014. Among these
patients, 61 CAP [5] and 78 HCAP [7] patients were
included in previous studies, and three of the CAP
patients and four of the HCAP patients in the past
studies were excluded because of insufficient samples
or data (Fig. 1). The patients were classified into two
groups: pneumonia patients with aspiration risk factors
and those without. This study was approved by the
Human and Animal Ethics Review Committee of the
University of Occupational and Environmental Health,
Japan (No.09–118). All patients provided written informed
consent.Definitions
CAP and HCAP were defined according to the Infec-
tious Diseases Society of America/American Thoracic
Society guidelines [3]. The criteria for aspiration risk fac-
tors defined by Marik et al. [12] were used, that consist
of having neurologic dysphagia, disruption of the gastro-
esophageal junction, or anatomical abnormalities of the
upper aerodigestive tract. Patients with gastroesophageal
disorders were categorized as “disruption of the gastro-
esophageal junction”. Eastern Cooperative Oncology
Group (ECOG) performance statuses (PS) were used,
Grade 0; fully active, able to carry on all pre-disease per-
formance without restriction, Grade one; restricted in
physically strenuous activity but ambulatory and able to
carry out work of a light or sedentary nature, e.g., light
house work, office work, Grade two; ambulatory and
capable of all self-care but unable to carry out any work
activities, up and about more than 50 % of waking hours,
Grade three; capable of only limited self-care, confined to
bed or chair more than 50 % of waking hours, Grade four;
Completely disabled, cannot carry on any self-care, totally
confined to bed or chair, grade five; dead [13]. In this
study, Streptococcus mutans group and the S. mitis group,
the S. salivarius group, and the S. anginosus group were
included as “oral streptococci” except for S. pneumoniae.
Data and sample collection
The clinical information of the patients, including the
laboratory and radiological information on chest X-
rays and computed tomography (CT) findings were
collected. BALF specimens using 40 ml of sterile sa-
line were obtained from pneumonia lesions, as de-
scribed previously [5, 7].
Total cell count and cell lysis efficiency analysis
The total bacterial cell count and cell lysis efficiency
were evaluated using epifluorescent microscopy, as pre-
viously described [5, 7, 8].
Microbiological evaluation using cultivation methods
The cultivation of BALF and sputum samples was per-
formed as previously described [5, 7]. Positive results were
recorded for all bacterial species. The presence of more
than one positive BALF and/or sputum culture is de-
scribed in the “Total” column of Table 2, while the posi-
tive culture results for BALF and sputum samples are
presented in the corresponding columns of Fig. 2.
The bacterial floral analysis of 16S ribosomal RNA gene
The DNA of 16S rRNA genes in BALF samples was
extracted and the partial 16S rRNA gene fragments
(approximately 580 base pairs) were amplified by a poly-
merase chain reaction (PCR) method with universal
primers (341F and 907R). The amplified products were
Fig. 1 A flow chart of the participants in this study. Definitions of abbreviations: CAP, community-acquired pneumonia; HCAP,
healthcare-associated pneumonia; BALF, bronchoalveolar lavage fluid
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kit (Invitrogen, Carlsbad, CA), and the nucleotide se-
quences of 96 randomly chosen clones were determined,
and comparison of the detected sequences with the type
strains using the basic local alignment search tool
(BLAST) algorithm were performed, as described previ-
ously [5, 7, 8]. Using this method, each bacterial phylo-
type was precisely estimated including differentiation of
S. pneumoniae and other streptococci in the BALF.
Statistical analysis
The SPSS software package (version 19) was used, and
Fisher’s exact test for tables (2 × 2), and the Mann–
Whitney U test were applied. P < 0.05 was considered
significant. When the most detected bacterial phylotypes
were considered as dependent variables and clinical vari-
ables were considered as independent variables, a simple
regression analysis was used. In addition, a multiple lin-
ear regression analysis was also performed. The variables
were included in the original simple regression analysis
model if their univariable P values were less than 0.05.
Results
Patient characteristics
The characteristics of 177 patients (CAP 83, HCAP 94)
are shown in Table 1, and 46.9 % (83/177) patients had
aspiration risks. Compared to the patients without aspir-
ation risks, the patients with aspiration risks were signifi-
cantly older, including more males and HCAP patients,higher rates of patients who resided in a nursing home or
an extended care facility, lower average body mass indices
(BMI), higher percentages of patients with median ECOG-
PS of 3–4 of premorbid conditions, patients using anti-
psychotic drugs and patients with history of pneumonia
within the previous 1 year (Table 1). The patients with as-
piration risks demonstrated significantly higher percentages
of patients with orientation disturbance, lower hematocrit
values and average serum albumin levels, and more patients
with posterior dominant distribution of infiltration on chest
CT and more patients with a Pneumonia Severity Index
(PSI) score of VI-V than the patients without aspiration
risks (Table 1).
Total bacterial cell numbers and cell lysis efficiency
analysis
The numbers of bacteria in the BALF samples ranged
from 1.2 × 104 to 3.7 × 109 (median, 3.7 × 109) cells/mL.
The cell lysis efficiency was maintained at ≥90 % in all
samples.
The comparison of conventional cultivation methods and
the bacterial floral analysis of 16S ribosomal RNA gene
The results of the conventional cultivation methods and
the most detected phylotypes using the bacterial floral
analysis of the 16S rRNA gene in the BALF samples are
shown in Fig. 2 and Table 2. The bacterial floral analysis
of 16S rRNA gene identified one or more bacterial phy-
lotypes in all of the BALF samples, whereas cultivation
Fig. 2 The percentages of the detected bacteria by sputum cultivation, and cultivation and the bacterial floral analysis of 16S ribosomal RNA gene in
bronchoalveolar lavage fluid. The percentages of the bacterial species detected by the cultivation using sputum samples (a, d and g) or
bronchoalveolar lavage fluid (BALF) (b, e and h), and the most detected bacterial phylotypes detected by the bacterial floral analysis of 16S rRNA gene
in BALF (c, f and i). The numbers in the Figures describe the percentages of detected bacteria in patients of all (a, b and c), with aspiration risks
(d, e and f) and without aspiration risks (g, h and i), respectively. The denominators in a, b, d, e, g and h are the numbers of patients in whom some
bacterial species were cultured, and the bacterial floral analysis of 16S rRNA gene detected at least one or more bacterial phylotypes in all of the BALF
samples (c, f and i). Ninety-one patients could not produce any sputum for examination at hospital admission (a, d and g). All members of the
Streptococcus mutans and S. mitis groups, the S. salivarius group, and the S. anginosus group were included as “oral streptococci” except for S.
pneumoniae (c, f and i). Definitions of abbreviations: MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant S. aureus
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BALF and 95.3 % (82/86) in sputum samples. The most
detected bacterial phylotypes determined in the BALF
using the bacterial floral analysis of 16S rRNA gene are
shown in Fig. 2 and Table 2. Oral streptococci (22.3 %),
Haemophilus spp. (15.6 %), S. pneumoniae (12.8 %), anaer-
obes (12.3 %), and Mycoplasma pneumoniae (7.8 %) were
mostly detected by the bacterial floral analysis of 16S
rRNA gene. In contrast, the cultivation methods detected
Haemophilus spp. (12.8 %), S. pneumoniae (11.7 %),
Staphylococcus aureus (11.7 %), and Pseudomonas aerugi-
nosa (10.0 %), while oral streptococci and anaerobes were
isolated in only 5.0 and 4.4 % of the samples, respectively
(Fig. 2 and Table 2).Comparison of the results of the bacterial floral analysis
of 16S ribosomal RNA gene between patients with or
without aspiration risks
Using the bacterial floral analysis of 16S rRNA gene,
oral streptococci as the most detected phylotypes
were significantly highly detected in patients with as-
piration risks than patients without (31.0 and 14.7 %,
respectively, P = 0.009); while anaerobes were signifi-
cantly more detected in patients without aspiration
risks (Fig. 2i) than patients with aspiration risks
(Fig. 2f ) (17.9 and 6.0 %, respectively, P = 0.015).
Additionally, the percentages of oral streptococci
were higher in patients with aspiration risks (Fig. 4a)
than those without aspiration risks (Fig. 4b) (Fig. 3a,












Age, years, mean±SD 76.6 (9.5) 64.5 (19.4) <0.001
Gender, male; n (%) 58 (69.9) 48 (51.1) 0.011
HCAP; n (%) 59 (71.1) 35 (37.2) <0.001
Hospitalization for >2 days
in the preceding 90 days
34 (41.0) 27 (28.7) 0.087
Residence in a nursing home
or extended care facility
29 (34.9) 5 (5.3) <0.001
Home infusion therapy
(including antibiotics)
10 (12.0) 8 (8.5) 0.437
Chronic dialysis during the
preceding 30 days
0 (0.0) 1 (1.1) 0.346
Home wound care 0 (0.0) 0 (0.0)
BMI, mean±SDa 19.6 (4.8) 20.7 (4.5) 0.038
ECOG PS, median (IQR) 2 (0.5–3.5) 1 (0.5–1.5) <0.001
0–1; n (%) 28 (33.7) 73 (77.7) <0.001
2; n (%) 22 (26.5) 12 (12.8)
3–4; n (%) 33 (39.8) 9 (9.6) <0.001
Smoking; n, (%)b
Smoker 7 (10.0) 9 (10.7)
Ex-smoker 30 (42.9) 30 (35.7)
Non smoker 33 (47.1) 45 (53.6)
B.Ic 493.7 (606.1) 449.4 (641.7) 0.454
Comorbidity; n, (%)
Chronic respiratory disease 22 (26.5) 38 (40.4) 0.051
COPD 11 (13.3) 23 (24.5) 0.059
Bronchiectasis 6 (7.2) 12 (12.8) 0.224
Lung cancer 7 (8.4) 3 (3.2) 0.132
Interstitial pneumonia 6 (7.2) 9 (9.6) 0.576
Cerebrovascular disease 30 (36.1) 0 (0.0) –
Neuromuscular diseases 19 (22.9) 0 (0.0) –
Dementia 26 (31.3) 0 (0.0) –
Pharyngeal disorder 7 (8.4) 0 (0.0) –
Gastroesophageal disorder 27 (32.5) 0 (0.0) –
Diabetes mellitus 11 (13.3) 22 (23.4) 0.084
Malignancy excluding lung
cancer
26 (31.3) 18 (19.1) 0.060
Congestive heart failure 8 (9.6) 8 (8.5) 0.794
Chronic kidney disease 2 (2.4) 5 (5.3) 0.450
Chronic liver disease 6 (7.2) 2 (2.1) 0.103
RA or Sjogren’s syndrome 0 (0.0) 9 (9.6) 0.004
Collagen disease 5 (6.0) 7 (7.4) 0.707
Psychiatric disease 2 (2.4) 4 (4.3) 0.686
Table 1 Characteristics of patients with or without risk factors
for aspiration (Continued)
Medications; n (%)
Sleeping medications 17 (20.5) 10 (10.6) 0.07
Glucocorticoids
(PSL>5 mg/day)
11 (13.3) 7 (7.4) 0.202
Immunosuppressive agent 3 (3.6) 8 (9.5) 0.178
Antipsychotic drugs 7 (8.4) 1 (1.1) 0.027
Antidepressant 3 (3.6) 6 (6.4) 0.504
History of pneumonia within
the previous 1 year; n (%)
24 (28.9) 15 (16.0) 0.038
Respiratory failure; n, (%) 31 (37.3) 30 (31.9) 0.448
Clinical parameters; n, (%)
Orientation disturbance
(confusion)
21 (25.3) 8 (8.5) 0.003
Systolic BP<90 mmHg or
diastolic BP<60 mmHg
5 (6.0) 2 (2.1) 0.255
Body temperature<35 °C
or >40 °C
4 (4.8) 1 (1.1) 0.188
Pulse rate>125 beats/min 5 (6.0) 10 (10.6) 0.271
Laboratory findings
BUN>10.7 mmol/L 28 (33.7) 24 (25.5) 0.232
Glucose>13.9 mmol/L 3 (3.6) 7 (7.4) 0.339
Hematocrit<30 % 16 (19.3) 6 (6.4) 0.010
Albumin, g/dl mean ± SDd 3.05 (0.61) 3.29 (0.57) 0.011
Radiographic findings; n, (%)e
Bilateral lung involvement 54 (65.1) 50 (53.8) 0.128
Upper lobe dominant opacity 14 (16.9) 20 (21.5) 0.437
Lower lobe opacity 54 (65.1) 52 (55.9) 0.216
anterior dominant opacity 8 (9.6) 14 (15.1) 0.278
posterior dominant opacity 67 (80.7) 58 (62.4) 0.007
Gravity-dependent opacity 67 (80.7) 67 (72.0) 0.178
Thickening of
bronchovascular bundles
37 (44.6) 50 (53.8) 0.224
Pleural effusion 12 (14.5) 19 (20.3) 0.299
PSI score; mean±SD 112.0 (40.3) 81.0 (46.3) <0.001
I-III 25 (30.1) 57 (60.6)
VI-V 53 (69.9) 37 (39.4) <0.001
In hospital mortality 6 (7.2) 6 (6.4) 0.823
Definition of abbreviations: SD standard devision, CAP community-acquired
pneumonia, HCAP healthcare-associated pneumonia, BMI body mass index,
ECOG PS eastern cooperative oncology group performance status, BI brinkman
index, COPD chronic obstructive pulmonary disease, RA rheumatoid Arthritis,
PSI pneumonia severity index
aBMI, bsmoking, cB.I, dserum albumin and, eradiographic findings were
evaluated in 142, 154, 153, 168, and 176 patients, respectively
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detected in patients without aspiration risks (Fig. 4d)
than those with aspiration risks (Fig. 4c) (Fig. 3b, P =
0.044).
Table 2 Predominant bacteria according to the bacterial floral analysis of 16S rRNA gene and cultivation methods
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Streptococcus pneumoniae 23 (12.8) 21 (11.7) 12 (13.0) 10 (11.9) 7 (8.0) 5 (12.0) 13 (13.7) 14 (15.2) 7 (13.7)
Streptococcus spp. 40 (22.3) 9 (5.0) 6 (6.5) 26 (31.0) 4 (4.5) 2 (4.8) 14 (14.7) 5 (5.4) 4 (7.8)
Streptococcus anginosus
group
5 (2.8) 1 (0.6) 0 (0.0) 5 (6.0) 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Other Streptococcus spp. 35 (19.6) 8 (4.4) 6 (6.5) 21 (25.0) 3 (3.4) 2 (4.8) 14 (14.7) 5 (5.4) 4 (7.8)
Staphylococcus aureus 8 (4.5) 21 (11.7) 15 (16.1) 4 (4.8) 11 (12.5) 8 (19.0) 4 (4.2) 10 (10.9) 7 (13.7)
Methicillin-susceptible
S. aureus
– 7 (3.9) 4 (4.3) – 5 (5.7) 1 (2.4) – 2 (2.2) 3 (5.9)
Methicillin-resistant
S. aureus
– 14 (7.8) 11 (11.8) – 6 (6.8) 7 (16.7) – 8 (8.7) 4 (7.8)
Staphylococcus spp.
(except S. aureus)
2 (1.1) 2 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.1) 2 (2.2) 0 (0.0)
Corynebacterium spp. 6 (3.4) 2 (1.1) 1 (1.1) 5 (6.0) 1 (1.1) 1 (2.4) 1 (1.1) 1 (1.1) 0 (0.0)
Gemella spp. 2 (1.1) 0 (0.0) 0 (0.0) 2 (2.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Lactobacillus spp. 1 (0.6) 0 (0.0) 0 (0.0) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Rothia spp. 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0)
Gram-negative pathogens
Haemophilus spp. 28 (15.6) 23 (12.8) 10 (10.8) 14 (16.7) 8 (9.1) 5 (12.0) 14 (14.7) 15 (16.3) 5 (9.8)
Pseudomonas aeruginosa 10 (5.6) 18 (10.0) 9 (9.7) 2 (2.4) 8 (9.1) 3 (7.1) 8 (8.4) 10 (10.9) 6 (11.8)
Pseudomonas spp.
(except P. aeruginosa)
0 (0.0) 2 (1.1) 1 (1.1) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0) 1 (1.1) 1 (2.0)
Moraxella spp. 8 (4.5) 7 (3.9) 4 (4.3) 5 (6.0) 5 (5.7) 1 (2.4) 3 (3.2) 2 (2.2) 3 (5.9)
Neisseria spp. 5 (2.8) 0 (0.0) 0 (0.0) 1 (1.2) 0 (0.0) 0 (0.0) 4 (4.2) 0 (0.0) 0 (0.0)
Klebsiella spp 4 (2.2) 12 (6.7) 6 (6.5) 3 (3.6) 10 (11.4) 6 (14.3) 1 (1.1) 2 (2.2) 0 (0.0)
Escherichia coli 2 (1.1) 5 (2.8) 2 (2.2) 2 (2.4) 5 (5.7) 2 (4.8) 0 (0.0) 0 (0.0) 0 (0.0)
Enterobacter spp. 1 (0.6) 2 (1.1) 2 (2.2) 1 (1.2) 2 (2.3) 1 (2.4) 0 (0.0) 0 (0.0) 1 (2.0)
Acinetobacter spp. 0 (0.0) 2 (1.1) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0)
Citrobacter spp. 0 (0.0) 1 (0.6) 1 (1.1) 0 (0.0) 1 (1.1) 1 (2.4) 0 (0.0) 0 (0.0) 0 (0.0)
Serratia spp. 0 (0.0) 2 (1.1) 0 (0.0) 0 (0.0) 2 (2.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Burkholderia spp. 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0)
Proteus spp. 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pasteurella spp. 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0)
Anaerobic pathogens 22 (12.3) 8 (4.4) 0 (0.0) 5 (6.0) 5 (5.7) 0 (0.0) 17 (17.9) 3 (3.3) 0 (0.0)
Prevotella spp. 11 (6.1) 3 (1.7) 0 (0.0) 4 (4.8) 2 (2.3) 0 (0.0) 7 (7.4) 1 (1.1) 0 (0.0)
Fusobacterium spp. 5 (2.8) 1 (0.6) 0 (0.0) 1 (1.2) 0 (0.0) 0 (0.0) 4 (4.2) 1 (1.1) 0 (0.0)
Micromonas spp. 2 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.1) 0 (0.0) 0 (0.0)
Propionibacterium spp. 2 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.1) 0 (0.0) 0 (0.0)
Veillonella spp. 1 (0.6) 2 (1.1) 0 (0.0) 0 (0.0) 2 (2.3) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0)
Porphyromonas spp 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0)
Peptostreptococcus spp. 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0)
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Table 2 Predominant bacteria according to the bacterial floral analysis of 16S rRNA gene and cultivation methods (Continued)
Clostridium spp. 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Atypical pathogens
Mycoplasma pneumoniae 14 (7.8) – – 2 (2.4) – – 12 (12.6) – –
Legionella pneumonia 1 (0.6) – – 1 (1.2) – – 0 (0.0) – –
Actinomyces spp. 0 (0.0) 2 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.2) 0 (0.0)
Nocardia spp. 1 (0.6) 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1) 1 (1.1) 0 (0.0)
Oral bacteria – 37 (20.9) 24 (25.8) – 16 (18.2) 7 (16.7) – 21 (22.8) 17 (33.3)
No growth – 32 (18.1) 4 (4.7) – 15 (18.1) 1 (2.8) – 17 (18.1) 3 (6.0)
Not analysed – – 91 (51.4) – – 47 (56.6) – – 44 (46.8)
Total isolates 179a 180 93 84b 88 42 95c 92 51
Data are presented as n (%) unless otherwise stated. Percentages refer to the total number of isolates except “No growth” and “Not analysed”. “No growth” and
“Not analysed” refer to the total number of cases. Definition of abbreviations: BALF: bronchoalveolar lavage fluid. a179 isolates of 177 cases (2 cases had two first
predominant bacterial species.).b84 isolates of 83 cases.c95 isolates of 94 cases
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for detecting oral streptococci
Simple regression analysis was performed, using the most
detected phylotypes such as oral streptococci (Fig. 2c) as
the dependent variable and clinical variables (Table 3) as
the independent variable. These variables were included inFig. 3 The occupancy of the phylotypes of oral streptococci and anaerobe
to aspiration risks and ECOG-PS. a and c represents the occupancy of the p
phylotypes of anaerobes, according to aspiration risks (a and b) and ECOG
bronchoalveolar lavage fluid, the occupancy rates of oral streptococci were
patients without aspiration risks (P = 0.02) (a), and were also significantly hi
with ECOG-PS of ≤2 (P < 0.001) (c). In contrast, the occupancy rates of anae
those in patients with aspiration risks (P = 0.044) (b), and similar trend was
patients with ECOG-PS of ≤2 (P = 0.085) (d). All members of the Streptococc
anginosus group, were included as “oral streptococci” except for S. pneumo
Group-Performance Statusthe original simple regression analysis model if their
univariable P values were less than 0.05. The significantly
correlated factors revealed by a simple regression analysis
were; at an age of ≥80, an ECOG-PS of ≥3, residing in a
nursing home or long-term care facility, the presence of
aspiration risks, and a history of pneumonia within thes by the bacterial floral analysis of 16S ribosomal RNA gene according
hylotypes of oral streptococci, and (b and d) shows the occupancy of
-PS (c and d). Using the bacterial floral analysis of 16S rRNA gene in
significantly higher in patients with aspiration risks than those in
gher in patients with ECOG-PS of ≥3 compared to those in patients
robes were significantly higher in patients without aspiration risks than
observed in patients with ECOG-PS of ≥3 compared to those in
us mutans and S. mitis groups, the S. salivarius group, and the S.
niae. Abbreviation: ECOG-PS; European Cooperative Oncology
Fig. 4 The percentages of oral streptococci (black), anaerobes (gray) and others (light gray) detected by the bacterial floral analysis of 16S
ribosomal RNA gene in each bronchoalveolar lavage fluid sample according to risks for aspiration and ECOG-PS. The percentages of oral
streptococci (black), anaerobes (gray) and others (light gray) detected by the bacterial floral analysis of 16S rRNA gene in each bronchoalveolar
lavage fluid sample in patients with (a and c) or without (b and d) risks for aspiration, and those in patients with ECOG-PS of ≥3 (e and g) or ≤2
(f and h). a, b, e and f focus on the detection rate of oral streptococci (black) in each patient, and c, d, g and h focus on the detection rate of
anaerobes (gray) in each patient. All members of the Streptococcus mutans and S. mitis groups, the S. salivarius group, and the S. anginosus group
were included as “oral streptococci” except for S. pneumoniae. Abbreviation: ECOG-PS; european cooperative oncology group performance status
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in the original simple regression analysis model if their
univariable P values were less than 0.05. In addition, a
multiple linear regression analysis revealed that an
ECOG-PS ≥3 and a history of pneumonia were associated
with the detection of oral streptococci in the BALF sam-
ples by the bacterial floral analysis of 16S ribosomal RNA
gene (Table 4).
Results of the bacterial floral analysis of 16S ribosomal
RNA gene in pneumonia patients with an ECOG-PS
of ≥3 or ≤2
As the most detected bacterial phylotypes, oral strepto-
cocci were significantly more frequently detected in pneu-
monia patients with an ECOG-PS of ≥3 than those ≤2
(P < 0.001), while anaerobes were less frequently detected
but not significantly different (Fig. 5). The percentages of
oral streptococci were significantly highly detected in eachBALF in patients with ECOG-PS ≥3 (Fig. 4e) than those
with ECOG-PS ≤2 (Fig. 4f) (Fig. 3c, P < 0.001), and those of
anaerobes were highly observed in each BALF in patients
with ECOG-PS ≤2 (Fig. 4h) than ECOG-PS ≥3 (Fig. 4g),
but not significantly different (Fig. 3d, P = 0.085).
Discussion
This study firstly analyzed the relationship between the bac-
terial flora in the lung and the aspiration risks in patients
with CAP and HCAP, and the bacterial floral analysis of
16S ribosomal RNA gene using the BALF specimens ob-
tained from 83 CAP and 94 HCAP patients revealed that
oral streptococci were the most detected bacterial phylo-
types (Fig. 2c). This is in line with our previous results that
demonstrated the significantly higher detection of oral
streptococci in CAP patients [5]. However, the clinical im-
plication of the detection of oral streptococci in relation to
risk factors for aspiration and clinical background factors
Table 3 Result of simple regresssion analysis for detected oral
streptococci
b SE (b) β p-value
Age >80 13.92 4.47 0.229 0.002
BMI<20 −4.07 2.89 −0.106 0.161
Hospitalization for >2 days in
the preceding 90 day; n (%)
4.15 4.63 0.068 0.371
Residence in a nursing home or
long-term care facility
14.48 5.49 0.196 0.009
Home infusion therapy
(including antibiotics)
9.88 7.26 0.102 0.170
ECOG PS of premorbid
condition>3
23.37 4.87 0.341 <0.001
COPD −0.28 5.60 −0.004 0.960
Interstitial pneumonia 0.18 7.92 0.002 0.982
Lung cancer −0.16 9.55 −0.001 0.987
Bronchiectasis −6.63 7.28 −0.069 0.364
Cerebrovascular disease 7.75 5.85 0.100 0.187
Neuromuscular diseases 8.62 7.09 0.092 0.226
Dementia 8.14 6.20 0.099 0.191
Gastroesophageal disorder 5.72 6.12 0.705 0.351
Pharyngeal disorder 19.48 11.22 0.130 0.084
Presence of the risk factor for
aspiration
12.78 4.31 0.219 0.004
Malignancy excluding lung
cancer
−1.73 5.10 −0.026 0.735
Psychiatric disease 1.68 12.18 0.010 0.891
Sleeping medications 10.24 6.08 0.126 0.094
Antipsychotic drugs −4.94 10.61 −0.035 0.642
Antidepressant 10.40 10.01 0.078 0.300
History of pneumonia within
the previous 1 year
16.12 4.92 0.241 0.001
Albumin<4 g/dl −3.25 6.56 −0.037 0.621
Bilateral lung involvement 0.01 4.37 0.0002 0.998
Lower lobe opacity −4.67 4.40 −0.08 0.291
Posterior dominant opacity 4.56 4.87 0.071 0.351
Gravity-dependent opacity −7.52 5.27 −0.107 0.155
Definition of abbreviations: BMI body mass index, ECOG PS eastern cooperative
oncology group performance status, HCAP healthcare-associated pneumonia,
COPD chronic obstructive pulmonary disease
Table 4 Result of multiple linear regresssion for detected oral
streptococci
b SE (b) β p-value
Age>80 6.61 4.62 0.109 0.154
Residence in a nursing home or
long-term care facility
−3.28 6.4 −0.044 0.609
ECOG PS of premorbid condition>3 17.52 5.96 0.256 <0.001
Presence of the risk factor for aspiration 5.69 4.54 0.097 0.211
History of pneumonia within the
previous 1 year
10.36 4.88 0.155 0.035
b: raw (unstandardised) regression coefficient, SE standard error of
b coefficient
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cocci were significantly more frequently detected with high
occupancy in pneumonia patients with aspiration risks than
in those without aspiration risks (Figs. 3a and 4a, b). More-
over, the high occupancy of oral streptococci in each sam-
ple was strongly correlated with ECOG-PS ≥ 3 (Figs. 3c and
4e, f). In addition, this study firstly showed that having a
poor ECOG-PS (≥3) and a history of pneumonia within the
previous one year showed a greater correlation with the de-
tection of oral streptococci in the BALF than having aspir-
ation risks (Table 4).Oral streptococci have been reported to be common
causative pathogens of pulmonary abscesses and empy-
ema thoracis [14–17], and the rate of oral streptococci
as causative pathogens in patients with CAP or HCAP
was reported to be 0.3–14.1 % [18–27]. Higher incidence
of oral streptococci (22.3 %) as the most detected phylo-
types in the BALF using the bacterial floral analysis of
16S rRNA gene was observed compared to the previous
reports including our report of CAP patients (9.4 %) [5].
In addition, higher rates of oral streptococci were de-
tected in both patients with aspiration risks (31.0 %) and
without (14.7 %) (Fig. 3c, f ) than the previously reported
detection rates of oral streptococci in patients with aspir-
ation (1.9–41.2 %) [14, 28–32] and non-aspiration pneu-
monia (3.6–9.1 %) [30, 32]. The different bacteriological
detection methods may have influenced these different
detection rates of oral streptococci [30, 32]. Conventional
cultivation methods cannot evaluate the bacterial ratio in
each sample, whereas the bacterial floral analysis of 16S
rRNA gene we used can estimate the ratio of bacterial
phylotypes in each sample. According to the result, the
percentages of oral streptococci in each BALF sample in
patients with aspiration risks were significantly higher
than those in patients without aspiration risks (Fig. 3a).
The factors correlated with the detection of oral strepto-
cocci in pneumonia patients by simple regression analysis
were similar to the previous reports (Table 3) [15]. Detec-
tion of oral streptococci by the bacterial floral analysis of
16S rRNA gene were strongly correlated to a risk of aspir-
ation in this study, and the strongest correlation factor for
the detection of oral streptococci in pneumonia patients
in this study was a poor ECOG-PS (≥3) (Table 4).
Oral streptococci (22.3 %) were the most frequently
detected bacterial phylotypes (Fig. 2c), whereas the con-
ventional cultivation method demonstrated that oral
streptococci and anaerobes were isolated in only 5.0 and
4.4 % of the same samples, respectively (Fig. 2b). In real-
word clinical settings, oral streptococci and anaerobes
might be considered as oral contaminants and could be
underestimated by cultivation methods. We have previ-
ously shown that the bacterial floral analysis of 16S
Fig. 5 The differences of the percentages of the most detected bacterial phylotypes determined by the bacterial floral analysis of 16S ribosomal
RNA gene according to ECOG-PS. The percentages of the most detected bacterial phylotypes by the bacterial floral analysis of 16S rRNA gene in
patients with ECOG-PS ≥3 (a) included significantly more oral streptococci than those in patients with ECOG-PS ≤2 (b) (P < 0.001). All members of
the Streptococcus mutans and S. mitis groups, the S. salivarius group, and the S. anginosus group were included as “oral streptococci” except for S.
pneumoniae. Abbreviation: ECOG-PS; european cooperative oncology group performance status
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able oral floral contaminations in noninfectious patients
with idiopathic interstitial pneumonias [5], and also all
patients showed a total bacterial cell count of >104 cells/
mL in BALF that was a useful diagnostic criterion for
pulmonary bacterial infection [5], therefore, we think
that the oral streptococci and anaerobes that were highly
detected in the lower respiratory tract in this study were
reliable, and speculate that oral streptococci have im-
portant roles in patients with pneumonia with aspiration
risk factors.
The detection rates of anaerobes in patients with aspir-
ation pneumonia were 87.5–100 % in the studies using
percutaneous transtracheal aspirates [28–30]. However,
Marik et al. suggested that these high rates might be
excessive [12], primarily due to their later sampling time
of percutaneous transtracheal aspirates in the clinical
course of the illness. This might include other complica-
tions such as abscesses, necrotizing pneumonia, or empy-
ema in the previous studies [28–30], and transtracheal
sampling may also have possibly provoked the aspiration
of the oropharyngeal flora during the procedure. Anaer-
obes were detected in only 11.6 % of samples in other re-
port evaluating using protected BALF specimens in
patients with severe aspiration pneumonia in a population
of institutionalized elderly [14], and no anaerobes were
detected using a protected specimen brush [31, 33]. The
bacterial floral analysis of 16S rRNA gene demonstrated
that anaerobes were detected in 12.3 % of this study popu-
lation (Fig. 2c), and significantly highly detected in pa-
tients without aspiration risks (17.9 %, Fig. 2i) than withaspiration risks (6.0 %, Fig. 2f). The percentages of anaer-
obes in each BALF sample in patients without aspiration
risks were also significantly higher than those with aspir-
ation risks (Figs. 3b and 4c, d), and according to these
results, anaerobes might not be the primary cause of
pneumonia in patients with aspiration risks. El-Solh et al.
[14] also reported the relationship between the detection
of anaerobes in the lower respiratory tract and oral hy-
giene, further studies are necessary to clarify these clinical
relationships.
This study is associated with several limitations. First,
this study was retrospective and subject to a recall bias.
Second, the universal primers that were used in the bac-
terial floral analysis could not amplify all of the bacterial
16S rRNA genes, and the sensitivity of the primers was
approximately 92 % of the total bacterial species regis-
tered in the Ribosomal Database Project II database,
whereas no reported human causative pathogens were
included in the remaining 8 %. Third, only approxi-
mately 100 clones were analyzed per library, suggest-
ing that bacterial 16S rRNA gene sequences present
at very small fractions (<1 % of each sample) in the
sample may occasionally be undetectable. In addition,
the sequencing depth was insufficient for the detec-
tion of mycobacterial species. Fourth, this study only
included patients in whom bronchoscopic examin-
ation was performed.
Conclusions
Using the bacterial floral analysis of 16S rRNA gene, oral
streptococci were the most detected bacterial phylotypes
Akata et al. BMC Pulmonary Medicine  (2016) 16:79 Page 11 of 12in CAP and HCAP patients with aspiration risks, and
both simple and multiple regression analyses demon-
strated that the detection of oral streptococci in the
BALF by the bacterial floral analysis of 16S rRNA gene
was strongly related to poor ECOG-PS (≥3). The evalu-
ation of the patients’ physical activities to estimate the
aspiration risks and bacterial etiologies might be import-
ant, and a poor ECOG-PS might be a clue to the higher
detection rate of oral streptococci in the lower respira-
tory tract in patients with CAP and HCAP.
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